Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 56
  • Home
  • Print this page
  • Email this page
Year : 2018  |  Volume : 5  |  Issue : 2  |  Page : 137-155

Targeted Therapy: Attacking Cancer with Molecular and Immunological Targeted Agents

Oncology Nursing Consultant, Kilauea, HI, USA

Correspondence Address:
Gail M Wilkes
Oncology Nursing Consultant, Kilauea, HI
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/apjon.apjon_79_17

Rights and Permissions

Today, personalized cancer therapy with targeted agents has taken center stage, and offers individualized treatment to many. As the mysteries of the genes in a cell's DNA and their specific proteins are defined, advances in the understanding of cancer gene mutations and how cancer evades the immune system have been made. This article provides a basic and simplified understanding of the available (Food and Drug Administration- approved) molecularly and immunologically targeted agents in the USA. Other agents may be available in Asia, and throughout the USA and the world, many more agents are being studied. Nursing implications for drug classes are reviewed.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded512    
    Comments [Add]    
    Cited by others 16    

Recommend this journal